德尔菲法构建学生传染病症状监测质量控制和预警效果评价指标体系

目的 构建学生传染病症状监测质量控制和预警效果评价指标体系,为指导学生传染病症状监测预警工作提供科学依据。方法 在文献查阅基础上,通过两轮德尔菲法专家咨询筛选学生传染病症状监测质量控制和预警效果评价指标,并通过层次分析法和专家评分法确立指标权重,构建指标体系。结果 32位专家两轮咨询的专家积极系数分别为87.5%(28/32)和100.0%(28/28),专家平均权威系数(Cr)为0.792,第二轮咨询专家协调系数为0.245(χ²=459.416,P<0.001),经指标筛选,形成由6项一级指标、19项二级指标和43项三级指标构成的学生传染病症状监测质量控制和预警效果评价指标体系。6项一级指标权重从高到低依次为信息质量(0.2281)、学校管理(0.2123)、疾控管理(0.1927)、预警信息管理(0.1450)、系统维护(0.2)和预警效果评价(0.1108)。结论 本研究建立了学生传染病症状监测质量控制和预警效果评价指标体系,本体系专家积极程度和权威程度较高,意见趋于一致,可为国内学生传染病症状监测工作提供参考。     

High Case-Fatality Rate for Human Anthrax,Northern Ghana, 2005–2016

The human cutaneous anthrax case-fatality rate is ≈1% when treated, 5%–20% when untreated. We report high case-fatality rates (median 35.0%; 95% CI 21.1%–66.7%) during 2005–2016 linked to livestock handling in northern Ghana, where veterinary resources are limited. Livestock vaccination and access to human treatment should be evaluated.     

Surveillance of COVID-19–Associated Multisystem Inflammatory Syndrome in Children,South Korea

A concerning development during the coronavirus disease pandemic has been multisystem inflammatory syndrome in children. Reports of this condition in East Asia have been limited. In South Korea, 3 cases were reported to the national surveillance system for multisystem inflammatory syndrome in children. All case-patients were hospitalized and survived with no major disease sequelae.     

五年住院病人医院感染率分析

目的 :了解五年中医院感染的动态变化情况 ,为控制医院感染提供依据。方法 :科室自报和专职人员补漏相结合 ,发现医院感染病例 ,调查所有住院病人。结果 :1994年 7月～ 1998年 10月 ,某医院住院病人共计 5 9413例 ,发生医院感染 362 2例次 ,总医院感染率 6 10 % ,1994～ 1998年感染率分别为 8 0 5 %、7 98%、6 16%、4 97%、4 5 1% ,呈持续下降。部位例次感染率以上呼吸道最高 ( 2 67% ) ,手术伤口 ( 1 15 % )次之 ,下呼吸道感染率( 1 0 8% )居第三位 ,但不同年份的不同部位感染率的位次略有变化 ,外科、儿科、内科感染率分别为 9 0 3%、8 0 6%和 6 70 % ,居前三位。但不同年份不同科室所居位次变化较大。结论 :医院感染率的持续下降 ,原因是多方面的 ,但监测工作对感染率的降低所起的作用 ,是不容忽视的。在医院感染控制时应以上一年的监测结果为依据 ,把感染率最高的科室作为重点 ,查找其感染率高的原因 ,并采取相应控制措施 ,降低其医院感染率。这样交替进行 ,最终将能达到降低全院感染率之目的     

Abdominal aortic aneurysm: epidemiology,screening and work-up for repair

Abdominal aortic aneurysm (AAA) is a dilatation of the infra-renal abdominal aorta to greater than 3 cm. Population screening is offered to men in the year of their 65th birthday in the UK. Patients with small, asymptomatic AAAs (<5.5 cm) are entered into surveillance programmes and have their cardiovascular risk factors managed aggressively. An AAA ≥5.5 cm diameter, or one which is symptomatic, should be considered for surgical repair to prevent rupture. Aneurysm repair can be undertaken using either an open surgical or endovascular approach; the decision should be tailored to the individual patient and made by the surgeon and patient, with input from a multi-disciplinary team.     

胆胰手术后假性动脉瘤诊断及治疗

胆胰疾病病人经外科手术、介入或内镜治疗后发生迟发性大出血时,救治困难、病死率高,而术后假性动脉瘤形成和破裂是主要原因。胆胰手术后假性动脉瘤成因复杂多样,瘤体破裂出血前临床症状隐匿。从致病机制源头预防假性动脉瘤形成、重视前哨出血等特征性临床症状,将会有效确保胆胰疾病病人围手术期安全性,提高术后迟发性大出血的救治成功率。     

Does the false-negative rate for 1 or 2 negative sentinel nodes after neo-adjuvant chemotherapy translate into a high local recurrence rate?

Prospective trials demonstrate that sentinel node (SN) biopsy after neo-adjuvant chemotherapy (NACT) has a significant false-negative rate (FNR) when only 1 or 2 SNs are removed. It is unknown whether this increased FNR correlates with an elevated risk of recurrence. Tumor Registry data at an NCI-Designated Comprehensive Cancer Center were reviewed from 2004 to 2018 for patients having a negative SN biopsy after NACT. Among 190 patients with histologically negative nodes after NACT having 1 (n = 42), 2 (n = 46), and ≥3 (n = 102) SNs, axillary recurrences occurred in 7.14%, 0%, and 1.96% (p = 0.09), breast recurrences occurred in 2.38%, 6.52%, and 0.98% (p = 0.12), and distance recurrences occurred in 16.67%, 8.70%, and 7.84% (p = 0.27), respectively. Time to first recurrence did not differ by SN count (p = 0.41). After adjustment for age, race, clinical stage, and receptor status, there were no differences in the rates of axillary (p = 0.26), breast (p = 0.44), or distance recurrence (p = 0.24) by numbers of SNs harvested. Median follow-up was 46.8 months. Despite higher post-NACT FNRs reported in randomized trials for patients having <3 sentinel nodes, recurrence rates were not significantly different for 1 versus 2 versus ≥3 SNs. This suggests that patients having 1 or 2 post-NACT SNs identified may not necessitate axillary dissection.     

Axillary management based on American college of surgeons oncology group Z0011 criteria makes it possible to omit intraoperative diagnosis of sentinel lymph nodes in early breast cancer patients

The ACOSOG Z0011 trial has resulted in the omission of axillary lymph node dissection (ALND) in early breast cancer patients with one or two metastatic sentinel lymph nodes (SLNs). There has been increasing interest in the necessity of intraoperative assessment of SLNs in patients treated based on the Z0011 criteria. We evaluated the utility of intraoperative assessment in these eligible patients. A total of 1396 patients were treated following the Z0011 criteria from April 2012 to December 2019. We examined the proportion and clinicopathological features of patients who underwent ALND due to three or more metastatic SLNs and the sensitivity of intraoperative assessment. Only 16 (1.1%) patients had three or more metastatic SLNs diagnosed by intraoperative assessment, and they immediately underwent ALND. Of the clinicopathological factors, high clinical tumor stage (p = 0.002) and high Ki-67 labeling index value (p = 0.056) were more likely to be associated with the presence of three or more metastatic SLNs. The major independent risk factor for three or more metastatic SLNs was high clinical tumor stage (OR 3.94 [95% CI 1.42–11.0]; p = 0.009). Intraoperative assessment had low sensitivity (70.5%) and a high false-negative rate (29.5%) in detecting SLN metastases. The main finding of our study was the small proportion of patients who required ALND due to three or more metastatic SLNs according to the Z0011 criteria. The Z0011 strategy enables intraoperative assessment of SLNs to be omitted in early breast cancer patients.     

Un sistema de vigilancia de salud pública para el cambio climático en las ciudades

This paper makes a first proposal for a public health surveillance system for climate change in cities, and describes the process that led to its definition. After several years of monitoring different aspects related to climate change and its impact, the public health services of Barcelona made a preliminary proposal and gathered a working group of experts to discuss and review it. Four categories of components were defined: climate data, health impacts of climate change and its determinants, contributions of the city to mitigation (especially those with health co-benefits), and actions to reduce vulnerability to extreme events. They were broken in twelve components, with indicators for each. The proposal was further refined with subsequent reviews, and is being used by the city public health services involved in this field.